MICHAEL J HARBOUR

Allopathic & Osteopathic Physicians|Internal Medicine|Infectious Disease STANFORD, CA NPI 1013022169

General Payments — all program years on this page

$89,136.50

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 127
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $11,486.12 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $11,383.7712
Gilead Sciences, Inc. $75.443
CMP Pharma, Inc. $26.911

By program year

Program yearAmountRecords
2018 $273.186
2019 $25,640.9845
2020 $31,742.1637
2021 $2,101.913
2022 $12,473.3213
2023 $5,418.837
2024 $11,486.1216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1094608578 CMP Pharma, Inc. $26.91 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825838 Gilead Sciences, Inc. $16.99 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825840 Gilead Sciences, Inc. $19.51 11/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133825842 Gilead Sciences, Inc. $38.94 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141686085 Merck Sharp & Dohme LLC $36.92 02/02/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141686099 Merck Sharp & Dohme LLC $150.00 11/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141686221 Merck Sharp & Dohme LLC $922.32 11/28/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141686223 Merck Sharp & Dohme LLC $75.00 12/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141686225 Merck Sharp & Dohme LLC $75.00 01/31/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141686227 Merck Sharp & Dohme LLC $3,255.00 12/18/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1141686229 Merck Sharp & Dohme LLC $5.82 12/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141686231 Merck Sharp & Dohme LLC $125.00 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141686233 Merck Sharp & Dohme LLC $119.70 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141865213 Merck Sharp & Dohme LLC $3,255.00 11/22/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1141865583 Merck Sharp & Dohme LLC $109.01 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141865683 Merck Sharp & Dohme LLC $3,255.00 02/02/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.